Flagship Ventures Fund V General Partner LLC
Insider CIK 1724575 · CDAK 10% owner · EVLO 10% owner · RUBY 10% owner · DNLI 10% owner · KLDO Director, 10% owner · SANA 10% owner · SGTX 10% owner · FHTX Director, 10% owner · OMGA 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| FHTX Foghorn Therapeutics Inc. | A Award deriv | 2026-01-13 | 2026-01-15 | 2,235,468 | $6.71 | $15.00M | 2,235,468 | SEC↗ |
| FHTX Foghorn Therapeutics Inc. | A Award deriv | 2026-01-13 | 2026-01-15 | 1,117,734 | — | $0 | 1,117,734 | SEC↗ |
| FHTX Foghorn Therapeutics Inc. | A Award deriv | 2026-01-13 | 2026-01-15 | 1,117,734 | — | $0 | 1,117,734 | SEC↗ |
| SANA Sana Biotechnology, Inc. | J Other | 2023-09-13 | 2023-09-15 | 345,069 | — | $0 | 1,035,208 | SEC↗ |
| SANA Sana Biotechnology, Inc. | J Other | 2023-09-13 | 2023-09-15 | 2,431,281 | — | $0 | 7,293,841 | SEC↗ |
| SANA Sana Biotechnology, Inc. | J Other | 2023-09-13 | 2023-09-15 | 1,181,745 | — | $0 | 0 | SEC↗ |
| SANA Sana Biotechnology, Inc. | J Other | 2023-09-13 | 2023-09-15 | 4,926,378 | — | $0 | 8,057,470 | SEC↗ |
| SANA Sana Biotechnology, Inc. | J Other | 2023-09-13 | 2023-09-15 | 70,813 | — | $0 | 0 | SEC↗ |
| SANA Sana Biotechnology, Inc. | J Other | 2023-09-13 | 2023-09-15 | 2,825,989 | — | $0 | 8,615,337 | SEC↗ |
| SGTX Sigilon Therapeutics, Inc. | U Tender | 2023-08-11 | 2023-08-15 | 683,760 | $14.92 | $10.20M | 0 | SEC↗ |
| SGTX Sigilon Therapeutics, Inc. | U Tender | 2023-08-11 | 2023-08-15 | 113,960 | $14.92 | $1.70M | 0 | SEC↗ |
| SANA Sana Biotechnology, Inc. | S Sale | 2023-06-07 | 2023-06-08 | 22,760 | $6.24 | $142.0K | 1,380,277 | SEC↗ |
| SANA Sana Biotechnology, Inc. | S Sale | 2023-06-07 | 2023-06-08 | 177,240 | $6.24 | $1.11M | 10,743,293 | SEC↗ |
| SANA Sana Biotechnology, Inc. | S Sale | 2023-06-06 | 2023-06-08 | 181,461 | $6.31 | $1.15M | 10,920,533 | SEC↗ |
| SANA Sana Biotechnology, Inc. | S Sale | 2023-06-06 | 2023-06-08 | 22,297 | $6.31 | $140.7K | 1,403,037 | SEC↗ |
| SANA Sana Biotechnology, Inc. | S Sale | 2023-05-26 | 2023-05-26 | 9,330 | $6.23 | $58.1K | 1,425,334 | SEC↗ |
| SANA Sana Biotechnology, Inc. | S Sale | 2023-05-26 | 2023-05-26 | 72,670 | $6.23 | $452.7K | 11,101,994 | SEC↗ |
| SANA Sana Biotechnology, Inc. | S Sale | 2023-05-25 | 2023-05-26 | 13,127 | $6.35 | $83.4K | 1,434,664 | SEC↗ |
| SANA Sana Biotechnology, Inc. | S Sale | 2023-05-25 | 2023-05-26 | 102,245 | $6.35 | $649.3K | 11,174,664 | SEC↗ |
| SANA Sana Biotechnology, Inc. | S Sale | 2023-05-24 | 2023-05-26 | 39,580 | $6.57 | $260.0K | 1,447,791 | SEC↗ |
| SANA Sana Biotechnology, Inc. | S Sale | 2023-05-24 | 2023-05-26 | 308,290 | $6.57 | $2.03M | 11,276,909 | SEC↗ |
| CDAK Codiak BioSciences, Inc. | P Buy deriv | 2022-09-15 | 2022-09-16 | 722,590 | — | $0 | 722,590 | SEC↗ |
| CDAK Codiak BioSciences, Inc. | P Buy deriv | 2022-09-15 | 2022-09-16 | 210,743 | — | $0 | 210,743 | SEC↗ |
| CDAK Codiak BioSciences, Inc. | P Buy | 2022-09-15 | 2022-09-16 | 210,743 | — | $0 | 1,188,920 | SEC↗ |
| CDAK Codiak BioSciences, Inc. | P Buy | 2022-09-15 | 2022-09-16 | 722,590 | — | $0 | 1,865,767 | SEC↗ |
| OMGA Omega Therapeutics, Inc. | C Conversion deriv | 2021-08-03 | 2021-08-05 | 22,275,232 | — | $0 | 0 | SEC↗ |
| OMGA Omega Therapeutics, Inc. | C Conversion deriv | 2021-08-03 | 2021-08-05 | 4,112,000 | — | $0 | 0 | SEC↗ |
| OMGA Omega Therapeutics, Inc. | C Conversion deriv | 2021-08-03 | 2021-08-05 | 27,388,000 | — | $0 | 0 | SEC↗ |
| OMGA Omega Therapeutics, Inc. | C Conversion deriv | 2021-08-03 | 2021-08-05 | 3,000,000 | — | $0 | 0 | SEC↗ |
| OMGA Omega Therapeutics, Inc. | C Conversion deriv | 2021-08-03 | 2021-08-05 | 2,666,667 | — | $0 | 0 | SEC↗ |
| OMGA Omega Therapeutics, Inc. | C Conversion deriv | 2021-08-03 | 2021-08-05 | 666,667 | — | $0 | 0 | SEC↗ |
| OMGA Omega Therapeutics, Inc. | C Conversion deriv | 2021-08-03 | 2021-08-05 | 13,333,333 | — | $0 | 0 | SEC↗ |
| OMGA Omega Therapeutics, Inc. | C Conversion deriv | 2021-08-03 | 2021-08-05 | 3,333,333 | — | $0 | 0 | SEC↗ |
| OMGA Omega Therapeutics, Inc. | C Conversion deriv | 2021-08-03 | 2021-08-05 | 1,666,667 | — | $0 | 0 | SEC↗ |
| OMGA Omega Therapeutics, Inc. | C Conversion deriv | 2021-08-03 | 2021-08-05 | 5,000,000 | — | $0 | 0 | SEC↗ |
| OMGA Omega Therapeutics, Inc. | C Conversion deriv | 2021-08-03 | 2021-08-05 | 1,666,666 | — | $0 | 0 | SEC↗ |
| OMGA Omega Therapeutics, Inc. | C Conversion | 2021-08-03 | 2021-08-05 | 970,588 | — | $0 | 970,588 | SEC↗ |
| OMGA Omega Therapeutics, Inc. | C Conversion | 2021-08-03 | 2021-08-05 | 1,323,529 | — | $0 | 1,323,529 | SEC↗ |
| OMGA Omega Therapeutics, Inc. | P Buy | 2021-08-03 | 2021-08-05 | 661,764 | $17.00 | $11.25M | 5,514,707 | SEC↗ |
| OMGA Omega Therapeutics, Inc. | C Conversion | 2021-08-03 | 2021-08-05 | 4,852,943 | — | $0 | 4,852,943 | SEC↗ |
| OMGA Omega Therapeutics, Inc. | P Buy | 2021-08-03 | 2021-08-05 | 294,117 | $17.00 | $5.00M | 1,617,646 | SEC↗ |
| OMGA Omega Therapeutics, Inc. | P Buy | 2021-08-03 | 2021-08-05 | 220,588 | $17.00 | $3.75M | 8,617,413 | SEC↗ |
| OMGA Omega Therapeutics, Inc. | C Conversion | 2021-08-03 | 2021-08-05 | 8,396,825 | — | $0 | 8,396,825 | SEC↗ |
| OMGA Omega Therapeutics, Inc. | C Conversion | 2021-08-03 | 2021-08-05 | 5,896,386 | — | $0 | 5,896,386 | SEC↗ |
| OMGA Omega Therapeutics, Inc. | C Conversion | 2021-08-03 | 2021-08-05 | 1,088,470 | — | $0 | 1,088,470 | SEC↗ |
| RUBY Rubius Therapeutics, Inc. | P Buy | 2021-03-19 | 2021-03-23 | 70,000 | $29.00 | $2.03M | 15,393,593 | SEC↗ |
| RUBY Rubius Therapeutics, Inc. | P Buy | 2021-03-19 | 2021-03-23 | 70,000 | $29.00 | $2.03M | 5,859,414 | SEC↗ |
| RUBY Rubius Therapeutics, Inc. | P Buy | 2021-03-19 | 2021-03-23 | 70,000 | $29.00 | $2.03M | 2,633,703 | SEC↗ |
| SANA Sana Biotechnology, Inc. | C Conversion deriv | 2021-02-08 | 2021-02-10 | 9,725,122 | — | $0 | 0 | SEC↗ |
| SANA Sana Biotechnology, Inc. | C Conversion deriv | 2021-02-08 | 2021-02-10 | 11,585,199 | — | $0 | 0 | SEC↗ |
| SANA Sana Biotechnology, Inc. | C Conversion deriv | 2021-02-08 | 2021-02-10 | 11,441,326 | — | $0 | 0 | SEC↗ |
| SANA Sana Biotechnology, Inc. | C Conversion deriv | 2021-02-08 | 2021-02-10 | 1,487,371 | — | $0 | 0 | SEC↗ |
| SANA Sana Biotechnology, Inc. | C Conversion | 2021-02-08 | 2021-02-10 | 1,487,371 | — | $0 | 1,487,371 | SEC↗ |
| SANA Sana Biotechnology, Inc. | C Conversion | 2021-02-08 | 2021-02-10 | 9,725,122 | — | $0 | 9,725,122 | SEC↗ |
| SANA Sana Biotechnology, Inc. | C Conversion | 2021-02-08 | 2021-02-10 | 11,441,326 | — | $0 | 11,441,326 | SEC↗ |
| SANA Sana Biotechnology, Inc. | C Conversion | 2021-02-08 | 2021-02-10 | 11,585,199 | — | $0 | 11,585,199 | SEC↗ |
| SGTX Sigilon Therapeutics, Inc. | C Conversion deriv | 2020-12-08 | 2020-12-10 | 4,444,444 | — | $0 | 0 | SEC↗ |
| SGTX Sigilon Therapeutics, Inc. | C Conversion deriv | 2020-12-08 | 2020-12-10 | 1,481,481 | — | $0 | 0 | SEC↗ |
| SGTX Sigilon Therapeutics, Inc. | C Conversion deriv | 2020-12-08 | 2020-12-10 | 370,370 | — | $0 | 0 | SEC↗ |
| SGTX Sigilon Therapeutics, Inc. | C Conversion deriv | 2020-12-08 | 2020-12-10 | 4,074,074 | — | $0 | 0 | SEC↗ |
| SGTX Sigilon Therapeutics, Inc. | C Conversion | 2020-12-08 | 2020-12-10 | 8,888,888 | — | $0 | 8,888,888 | SEC↗ |
| SGTX Sigilon Therapeutics, Inc. | C Conversion | 2020-12-08 | 2020-12-10 | 1,481,481 | — | $0 | 1,481,481 | SEC↗ |
| FHTX Foghorn Therapeutics Inc. | C Conversion deriv | 2020-10-27 | 2020-10-29 | 2,666,666 | — | $0 | 0 | SEC↗ |
| FHTX Foghorn Therapeutics Inc. | C Conversion deriv | 2020-10-27 | 2020-10-29 | 1,336,293 | — | $0 | 0 | SEC↗ |
| FHTX Foghorn Therapeutics Inc. | C Conversion deriv | 2020-10-27 | 2020-10-29 | 3,333,333 | — | $0 | 0 | SEC↗ |
| FHTX Foghorn Therapeutics Inc. | C Conversion deriv | 2020-10-27 | 2020-10-29 | 8,333,333 | — | $0 | 0 | SEC↗ |
| FHTX Foghorn Therapeutics Inc. | C Conversion deriv | 2020-10-27 | 2020-10-29 | 7,500,000 | — | $0 | 0 | SEC↗ |
| FHTX Foghorn Therapeutics Inc. | P Buy | 2020-10-27 | 2020-10-29 | 50,000 | $16.00 | $800.0K | 9,330,878 | SEC↗ |
| FHTX Foghorn Therapeutics Inc. | C Conversion | 2020-10-27 | 2020-10-29 | 4,504,504 | — | $0 | 8,558,558 | SEC↗ |
| FHTX Foghorn Therapeutics Inc. | C Conversion | 2020-10-27 | 2020-10-29 | 4,054,054 | — | $0 | 4,054,054 | SEC↗ |
| FHTX Foghorn Therapeutics Inc. | C Conversion | 2020-10-27 | 2020-10-29 | 1,441,441 | — | $0 | 1,441,441 | SEC↗ |
| FHTX Foghorn Therapeutics Inc. | P Buy | 2020-10-27 | 2020-10-29 | 50,000 | $16.00 | $800.0K | 1,491,441 | SEC↗ |
| FHTX Foghorn Therapeutics Inc. | C Conversion | 2020-10-27 | 2020-10-29 | 722,320 | — | $0 | 9,280,878 | SEC↗ |
| FHTX Foghorn Therapeutics Inc. | C Conversion | 2020-10-27 | 2020-10-29 | 1,801,801 | — | $0 | 1,801,801 | SEC↗ |
| FHTX Foghorn Therapeutics Inc. | P Buy | 2020-10-27 | 2020-10-29 | 50,000 | $16.00 | $800.0K | 1,851,801 | SEC↗ |
| CDAK Codiak BioSciences, Inc. | C Conversion deriv | 2020-10-16 | 2020-10-20 | 2,416,666 | — | $0 | 0 | SEC↗ |
| CDAK Codiak BioSciences, Inc. | C Conversion deriv | 2020-10-16 | 2020-10-20 | 660,048 | — | $0 | 0 | SEC↗ |
| CDAK Codiak BioSciences, Inc. | C Conversion deriv | 2020-10-16 | 2020-10-20 | 660,048 | — | $0 | 0 | SEC↗ |
| CDAK Codiak BioSciences, Inc. | C Conversion deriv | 2020-10-16 | 2020-10-20 | 2,416,666 | — | $0 | 0 | SEC↗ |
| CDAK Codiak BioSciences, Inc. | C Conversion deriv | 2020-10-16 | 2020-10-20 | 4,250,000 | — | $0 | 0 | SEC↗ |
| CDAK Codiak BioSciences, Inc. | C Conversion deriv | 2020-10-16 | 2020-10-20 | 4,250,000 | — | $0 | 0 | SEC↗ |
| CDAK Codiak BioSciences, Inc. | C Conversion | 2020-10-16 | 2020-10-20 | 543,686 | — | $0 | 543,686 | SEC↗ |
| CDAK Codiak BioSciences, Inc. | C Conversion | 2020-10-16 | 2020-10-20 | 543,686 | — | $0 | 543,686 | SEC↗ |
| CDAK Codiak BioSciences, Inc. | C Conversion | 2020-10-16 | 2020-10-20 | 338,630 | — | $0 | 882,316 | SEC↗ |
| CDAK Codiak BioSciences, Inc. | C Conversion | 2020-10-16 | 2020-10-20 | 338,630 | — | $0 | 882,316 | SEC↗ |
| CDAK Codiak BioSciences, Inc. | C Conversion | 2020-10-16 | 2020-10-20 | 95,861 | — | $0 | 978,177 | SEC↗ |
| CDAK Codiak BioSciences, Inc. | C Conversion | 2020-10-16 | 2020-10-20 | 95,861 | — | $0 | 978,177 | SEC↗ |
| CDAK Codiak BioSciences, Inc. | P Buy | 2020-10-16 | 2020-10-20 | 165,000 | $15.00 | $2.48M | 1,143,177 | SEC↗ |
| KLDO Kaleido Biosciences, Inc. | C Conversion deriv | 2019-03-04 | 2019-03-06 | 1,251,251 | — | $0 | 0 | SEC↗ |
| KLDO Kaleido Biosciences, Inc. | C Conversion deriv | 2019-03-04 | 2019-03-06 | 1,251,251 | — | $0 | 0 | SEC↗ |
| KLDO Kaleido Biosciences, Inc. | C Conversion deriv | 2019-03-04 | 2019-03-06 | 2,570,694 | — | $0 | 0 | SEC↗ |
| KLDO Kaleido Biosciences, Inc. | C Conversion deriv | 2019-03-04 | 2019-03-06 | 1,928,021 | — | $0 | 0 | SEC↗ |
| KLDO Kaleido Biosciences, Inc. | C Conversion deriv | 2019-03-04 | 2019-03-06 | 642,674 | — | $0 | 0 | SEC↗ |
| KLDO Kaleido Biosciences, Inc. | C Conversion deriv | 2019-03-04 | 2019-03-06 | 1,278,720 | — | $0 | 0 | SEC↗ |
| KLDO Kaleido Biosciences, Inc. | C Conversion deriv | 2019-03-04 | 2019-03-06 | 852,480 | — | $0 | 0 | SEC↗ |
| KLDO Kaleido Biosciences, Inc. | C Conversion deriv | 2019-03-04 | 2019-03-06 | 9,275,111 | — | $0 | 0 | SEC↗ |
| KLDO Kaleido Biosciences, Inc. | C Conversion deriv | 2019-03-04 | 2019-03-06 | 3,091,704 | — | $0 | 0 | SEC↗ |
| KLDO Kaleido Biosciences, Inc. | C Conversion | 2019-03-04 | 2019-03-06 | 426,240 | — | $0 | 1,972,092 | SEC↗ |
| KLDO Kaleido Biosciences, Inc. | P Buy | 2019-03-04 | 2019-03-06 | 333,333 | $15.00 | $5.00M | 2,244,305 | SEC↗ |
| KLDO Kaleido Biosciences, Inc. | C Conversion | 2019-03-04 | 2019-03-06 | 625,625 | — | $0 | 6,227,190 | SEC↗ |
| KLDO Kaleido Biosciences, Inc. | C Conversion | 2019-03-04 | 2019-03-06 | 1,285,347 | — | $0 | 1,285,347 | SEC↗ |
| KLDO Kaleido Biosciences, Inc. | C Conversion | 2019-03-04 | 2019-03-06 | 964,010 | — | $0 | 5,601,565 | SEC↗ |
| KLDO Kaleido Biosciences, Inc. | C Conversion | 2019-03-04 | 2019-03-06 | 321,337 | — | $0 | 2,293,429 | SEC↗ |
| KLDO Kaleido Biosciences, Inc. | C Conversion | 2019-03-04 | 2019-03-06 | 639,360 | — | $0 | 639,360 | SEC↗ |
| KLDO Kaleido Biosciences, Inc. | C Conversion | 2019-03-04 | 2019-03-06 | 625,625 | — | $0 | 1,910,972 | SEC↗ |
| KLDO Kaleido Biosciences, Inc. | C Conversion | 2019-03-04 | 2019-03-06 | 4,637,555 | — | $0 | 4,637,555 | SEC↗ |
| KLDO Kaleido Biosciences, Inc. | C Conversion | 2019-03-04 | 2019-03-06 | 1,545,852 | — | $0 | 1,545,852 | SEC↗ |
| KLDO Kaleido Biosciences, Inc. | P Buy | 2019-03-04 | 2019-03-06 | 266,667 | $15.00 | $4.00M | 2,560,096 | SEC↗ |
| KLDO Kaleido Biosciences, Inc. | P Buy | 2019-03-04 | 2019-03-06 | 333,333 | $15.00 | $5.00M | 6,560,523 | SEC↗ |
| EVLO Evelo Biosciences, Inc. | C Conversion deriv | 2018-05-11 | 2018-05-15 | 4,643,963 | — | $0 | 0 | SEC↗ |
| EVLO Evelo Biosciences, Inc. | C Conversion deriv | 2018-05-11 | 2018-05-15 | 18,611,110 | — | $0 | 0 | SEC↗ |
| EVLO Evelo Biosciences, Inc. | C Conversion deriv | 2018-05-11 | 2018-05-15 | 8,333,000 | — | $0 | 0 | SEC↗ |
| EVLO Evelo Biosciences, Inc. | C Conversion deriv | 2018-05-11 | 2018-05-15 | 5,416,667 | — | $0 | 0 | SEC↗ |
| EVLO Evelo Biosciences, Inc. | C Conversion deriv | 2018-05-11 | 2018-05-15 | 10,102,055 | — | $0 | 0 | SEC↗ |
| EVLO Evelo Biosciences, Inc. | C Conversion deriv | 2018-05-11 | 2018-05-15 | 12,536,945 | — | $0 | 0 | SEC↗ |
| EVLO Evelo Biosciences, Inc. | C Conversion | 2018-05-11 | 2018-05-15 | 14,622,143 | — | $0 | 17,952,153 | SEC↗ |
| EVLO Evelo Biosciences, Inc. | P Buy | 2018-05-11 | 2018-05-15 | 281,250 | $16.00 | $4.50M | 18,233,403 | SEC↗ |
| DNLI Denali Therapeutics Inc. | C Conversion deriv | 2017-12-12 | 2017-12-12 | 125,000 | — | $0 | 0 | SEC↗ |
| DNLI Denali Therapeutics Inc. | C Conversion deriv | 2017-12-12 | 2017-12-12 | 156,250 | — | $0 | 0 | SEC↗ |
| DNLI Denali Therapeutics Inc. | C Conversion deriv | 2017-12-12 | 2017-12-12 | 8,324,999 | — | $0 | 0 | SEC↗ |
| DNLI Denali Therapeutics Inc. | C Conversion | 2017-12-12 | 2017-12-12 | 8,606,249 | — | $0 | 8,918,749 | SEC↗ |